Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
50

Summary

Conditions
  • BRAF Mutant Colorectal Cancer
  • Cervical Squamous Cell Cancer
  • Esophageal Squamous Cell Cancer
  • Head and Neck Squamous Cell Cancer
  • Lung Squamous Cell Cancer
  • Melanoma
  • Pancreatic Cancer
  • Triple -Negative Breast Cancer
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01351103
Collaborators
Not Provided
Investigators
Study Director: Novartis Pharmaceuticals Novartis Pharmaceuticals